All Stories

  1. Potential Role of Novel Cardiovascular Biomarkers in Pediatric Patients with Chronic Kidney Disease
  2. Bartter-like Syndrome Induced By Tacrolimus in a Renal Transplanted Boy: A Case Report
  3. Nephrotic Syndrome and Renin-angiotensin System: Pathophysiological Role and Therapeutic Potential
  4. Imaging Markers of Neurologic Damage in COVID-19: A Systematic Review
  5. The challenges of chemotherapy adjustment in obese individuals
  6. Nephrogenesis, Renal Function, and Biomarkers in Preterm Newborns
  7. The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants
  8. Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
  9. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
  10. COVID-19 and Renal Diseases: An Update
  11. COVID-19 related coagulopathy: what is known up to now
  12. Hepatorenal syndrome in children: a review
  13. 2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus
  14. Immune-Based Therapies for Traumatic Brain Injury: Insights from Pre-Clinical Studies
  15. Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations
  16. ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors
  17. Covid-19: the renin–angiotensin system imbalance hypothesis
  18. Bartter’s syndrome: clinical findings, genetic causes and therapeutic approach
  19. Biomarkers in vesicoureteral reflux: an overview
  20. Urinary tract infection in pediatrics: an overview
  21. Prevalence and risk factors for albuminuria and glomerular hyperfiltration in a large cohort of children with sickle cell anemia
  22. The Renin Angiotensin System and Bipolar Disorder: A Systematic Review
  23. Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade
  24. Association between dyslipidemia and CCL2 in patients undergoing hemodialysis
  25. Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia
  26. Science funding crisis in Brazil and COVID-19: deleterious impact on scientific output
  27. Renin-angiotensin system and Alzheimer’s disease pathophysiology: From the potential interactions to therapeutic perspectives
  28. The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence
  29. Inflammatory biomarkers in children with cerebral palsy: A systematic review
  30. Potential Role of Nutrient Intake and Malnutrition as Predictors of Uremic Oxidative Toxicity in Patients with End-Stage Renal Disease
  31. Urinary tract infection in pediatrics: an overview
  32. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study
  33. Cell‐Derived Microparticles and Von Willebrand Factor in Brazilian Renal Transplant Recipients
  34. A clinical predictive model of renal injury in children with isolated antenatal hydronephrosis
  35. Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients
  36. Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension
  37. Profile and scientific output of researchers recipients of CNPq productivity grant in the field of medicine
  38. Distal renal tubular acidosis: genetic causes and management
  39. The protective arm of the renin‐angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves
  40. A Predictive Model of Postnatal Surgical Intervention in Children With Prenatally Detected Congenital Anomalies of the Kidney and Urinary Tract
  41. Pediatric Patients With Steroid-Sensitive Nephrotic Syndrome Have Higher Expression of T Regulatory Lymphocytes in Comparison to Steroid-Resistant Disease
  42. Interactions between local Renin Angiotensin System and nitric oxide in the brain of Trypanosoma cruzi infected rats
  43. Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract
  44. Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease
  45. Brazil's endangered postgraduate system
  46. The copy number variation landscape of congenital anomalies of the kidney and urinary tract
  47. Evidence for a role of Angiotensin Converting Enzyme 2 in proteinuria of idiopathic nephrotic syndrome
  48. First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection
  49. Pediatric lupus nephritis
  50. Posterior urethral valves: comparison of clinical outcomes between postnatal and antenatal cohorts
  51. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease
  52. Neurotrophic Factors in Parkinson’s Disease: What Have we Learned from Pre-Clinical and Clinical Studies?
  53. A clinical predictive model of renal injury in children with congenital solitary functioning kidney
  54. A clinical predictive model of chronic kidney disease in children with posterior urethral valves
  55. RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders
  56. Glomerular hyperfiltration and β-2 microglobulin as biomarkers of incipient renal dysfunction in cancer survivors
  57. Dental Alterations in Renal Tubular Acidosis: Case Reports
  58. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer’s Disease
  59. Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia
  60. Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia
  61. Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals
  62. Inflammatory molecules and neurotrophic factors as biomarkers of neuropsychomotor development in preterm neonates: A Systematic Review
  63. The protective arm of the renin–angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves
  64. Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis
  65. Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis
  66. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System
  67. Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence
  68. T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome
  69. Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study
  70. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research
  71. Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?
  72. Single Nucleotide Variants in A Family of Monozygotic Twins Discordant for the Phenotype Congenital Megaureter: A Genomic Analysis
  73. Kidney–brain axis inflammatory cross-talk: from bench to bedside
  74. Erratum to: mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
  75. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
  76. Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules
  77. Bj-PRO-5a and Bj-PRO 10c Found at C-Type Natriuretic Peptide Precursor of Bothrops jararaca Change Renal Function of Hypertensive Rats
  78. Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study
  79. A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates
  80. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy
  81. Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis
  82. Renin angiotensin system in liver diseases: Friend or foe?
  83. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients
  84. Early changes in adipokines from overweight to obesity in children and adolescents
  85. Characterization of an experimental model of progressive renal disease in rats
  86. Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson's disease
  87. Early changes in adipokines from overweight to obesity in children and adolescents
  88. Zika virus challenges for neuropsychiatry
  89. Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome
  90. Immunoglobulin A nephropathy: a pathophysiology view
  91. Immune markers in the RASopathy neurofibromatosis type 1
  92. ACE inhibition, ACE2 and angiotensin-(1–7) axis in kidney and cardiac inflammation and fibrosis
  93. Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients
  94. Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis
  95. Frequência de sobrepeso e obesidade em crianças e adolescentes com autismo e transtorno do déficit de atenção/hiperatividade
  96. Nutritional evaluation of children with chronic cholestatic disease
  97. Nutritional evaluation of children with chronic cholestatic disease
  98. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood
  99. Chemokines as Potential Markers in Pediatric Renal Diseases
  100. Uromodulin: a new biomarker of fetal renal function?
  101. Update on the approach of urinary tract infection in childhood
  102. Whole-exome sequencing as a diagnostic tool for distal renal tubular acidosis
  103. Update on the approach of urinary tract infection in childhood
  104. Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report
  105. Propriedades psicométricas da Escala de Responsividade Social-2 para Transtornos do Espectro Autista
  106. Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease
  107. Dental findings in Brazilian patients with Fanconi syndrome
  108. A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome
  109. The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update
  110. Anthropometric and Biochemical Profile of Children and Adolescents with Chronic Kidney Disease in a Predialysis Pediatric Interdisciplinary Program
  111. Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients
  112. Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome
  113. Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: A preliminary study
  114. Mas in the Kidney
  115. Chemokines as Potential Markers in Pediatric Renal Diseases
  116. Mas and Inflammation
  117. Profile and scientific production of the Brazilian Council for Scientific and Technological Development (CNPq) researchers in the field of Hematology/Oncology
  118. Congenital anomalies of the kidney and urinary tract: An embryogenetic review
  119. Angiotensin type 2 receptor gene are associated with ureteropelvic junction obstruction
  120. A predictive model of chronic kidney disease in patients with congenital anomalies of the kidney and urinary tract
  121. PAX2 Polymorphisms and Congenital Abnormalities of the Kidney and Urinary Tract in a Brazilian Pediatric Population: Evidence for a Role in Vesicoureteral Reflux
  122. The Therapeutic Role of Renin-Angiotensin System Blockers in Obesity- Related Renal Disorders
  123. Dental Manifestations in Two Patients With Bartter’s Syndrome
  124. Progression of CKD in children
  125. Chemokines as Potential Markers in Pediatric Renal Diseases
  126. Study of the association between the BMP4 gene and congenital anomalies of the kidney and urinary tract
  127. Cognitive alterations in chronic kidney disease: an update
  128. Neuropsychiatric disorders and renal diseases: an update
  129. Action of a pancreatin and an Aspergillus oryzae protease on whey proteins: correlation among the methods of analysis of the enzymatic hydrolysates
  130. The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies
  131. Diagnostic Accuracy of Renal Pelvic Dilatation for Detecting Surgically Managed Ureteropelvic Junction Obstruction
  132. Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis
  133. Use of Different Proteases to Obtain Whey Protein Concentrate Hydrolysates with Inhibitory Activity toward Angiotensin-Converting Enzyme
  134. Beneficial Effects of the Activation of the Angiotensin-(1–7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy
  135. Enzymatic hydrolysis of whey protein concentrate: effect of enzyme type and enzyme:substrate ratio on peptide profile
  136. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
  137. Is there a correlation between journal impact factor and researchers’ performance? A study comprising the fields of clinical nephrology and neurosciences
  138. Assessing pre-clinical ventricular dysfunction in obese children and adolescents: the value of speckle tracking imaging
  139. Autoimmune hepatitis in childhood: The role of genetic and immune factors
  140. Correlation between the Degree of Hydrolysis and the Peptide Profile of Whey Protein Concentrate Hydrolysates: Effect of the Enzyme Type and Reaction Time
  141. Interactions between Cytokines, Congenital Anomalies of Kidney and Urinary Tract and Chronic Kidney Disease
  142. Perfil e análise da produção científica dos pesquisadores brasileiros em Neurociência Clínica
  143. Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases
  144. Máscara laríngea ProSealTM como via de administração de surfactante no tratamento da síndrome do desconforto respiratório em recém-nascido pré-termo
  145. Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study
  146. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis
  147. Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns
  148. Aplicação da biologia molecular na abordagem da síndrome de Bartter: relato de caso
  149. ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis
  150. Clinical Course of 822 Children with Prenatally Detected Nephrouropathies
  151. Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria
  152. Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
  153. Current knowledge on esophageal atresia
  154. Diagnostic criteria for autoimmune hepatitis in children: A challenge for pediatric hepatologists
  155. Imaging for evaluation of urologic abnormalities in infants with fetal hydronephrosis: advances and controversies
  156. Newer Doppler echocardiography techniques in assessment of heart function in obese patients
  157. Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury
  158. Typical Features of Amelogenesis Imperfecta in Two Patients with Bartter’s Syndrome
  159. ADAMTS13 and Von Willebrand factor assessment before and after kidney transplantation
  160. The renin–angiotensin–aldosterone system in 2011: role in hypertension and chronic kidney disease
  161. Comparison of Brazilian researchers in clinical medicine: are criteria for ranking well-adjusted?
  162. Inflamação na doença renal crônica: papel de citocinas
  163. Pesquisadores do Conselho Nacional de Desenvolvimento Científico e Tecnológico na área de Cardiologia
  164. Características clínicas e laboratoriais associadas à nefroangioesclerose hipertensiva confi rmada por biópsia renal
  165. Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods
  166. Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies
  167. Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups
  168. Angiotensin-converting enzyme inhibition changes the metabolic response to neuroglucopenic stress
  169. Bone disease and cytokines in idiopathic hypercalciuria: a review
  170. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity
  171. Combined Use of Late Phase Dimercapto-Succinic Acid Renal Scintigraphy and Ultrasound as First Line Screening After Urinary Tract Infection in Children
  172. Primary versus secondary hypertension in children followed up at an outpatient tertiary unit
  173. Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease
  174. Anti-Inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, Mas, in Experimental Models of Arthritis
  175. ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats
  176. Is remifentanil an option for premedication for neonatal endotracheal intubation?
  177. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis
  178. Risk Factors for Recurrent Urinary Tract Infections in a Cohort of Patients With Primary Vesicoureteral Reflux
  179. Risk Factors for Early Onset of Diabetic Nephropathy in Pediatric Type 1 Diabetes
  180. Citocinas e quimiocinas no transplante renal
  181. Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice
  182. Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria
  183. Molecular Pathophysiology of Renal Tubular Acidosis
  184. Independent risk factors for renal damage in a series of primary vesicoureteral reflux: A multivariate analysis
  185. Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis
  186. Renin-angiotensin system in the pathogenesis of liver fibrosis
  187. Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and Proteinuria
  188. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme
  189. The renin–angiotensin system and diabetes: An update
  190. Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program
  191. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
  192. Development of hepatorenal syndrome in bile duct ligated rats
  193. Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients
  194. Early awakening and extubation with remifentanil in ventilated premature neonates
  195. Sedação e analgesia em neonatologia
  196. Avaliação da dor em neonatologia
  197. The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes
  198. The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)
  199. Morphine versus remifentanil for intubating preterm neonates
  200. Risk of hypertension in primary vesicoureteral reflux
  201. Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease
  202. Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein
  203. Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies
  204. Predictive factors of chronic kidney disease in severe vesicoureteral reflux
  205. The Therapeutic Potential of Angiotensin-(1-7) as a Novel Renin- Angiotensin System Mediator
  206. Remifentanil for sedation and analgesia in a preterm neonate with respiratory distress syndrome
  207. Successful management of concomitant omphalocele, accessory hepatic lobe, and biliary atresia in a 44-day-old boy
  208. Nonpeptide AVE 0991 Is an Angiotensin-(1-7) Receptor Mas Agonist in the Mouse Kidney
  209. New method of surgical delayed closure of giant omphaloceles: Lazaro da Silva’s technique
  210. The renin angiotensin system in childhood hypertension: Selective increase of angiotensin-(1-7) in essential hypertension
  211. Angiotensin-(1–7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors
  212. Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
  213. Characterization of a New Selective Antagonist for Angiotensin-(1-7), D-Pro7-Angiotensin-(1-7)
  214. Spontaneous improvement of hypertension in multicystic dysplastic kidney: a case report
  215. Interactions Between Angiotensin-(1-7), Kinins, and Angiotensin II in Kidney and Blood Vessels
  216. VISCERAL LARVA MIGRANS AND TROPICAL PYOMYOSITIS: A CASE REPORT
  217. Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats
  218. Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats
  219. Renal actions of angiotensin-(1-7)
  220. Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance
  221. Characterization of a new angiotensin antagonist selective for angiotensin-(1–7): Evidence that the actions of angiotensin-(1–7) are mediated by specific angiotensin receptors
  222. Angiotensins